Today: 20 May 2026
Prudential share price ticks higher as insurers firm; PRU.L in focus ahead of Fed week
26 January 2026
1 min read

Prudential share price ticks higher as insurers firm; PRU.L in focus ahead of Fed week

London, Jan 26, 2026, 09:33 GMT — Regular session

  • Prudential shares climbed roughly 0.8% in early London trading, following gains across the insurance sector
  • European stocks held steady while investors digested tariff news ahead of a U.S. rate decision set for later this week
  • Prudential’s buyback continues to provide near-term support, with full-year results looming as the next key event

Prudential plc shares ticked higher on Monday, gaining roughly 0.8% to hover near 1,159 pence in early trades, following Friday’s close at 1,149.5 pence.

The move was notable since insurers stood out in Europe, edging up roughly 0.7%. Investors remained wary after recent tariff jitters and turned their focus toward the U.S. Federal Reserve’s policy decision due later this week.

Prudential’s shares have also benefited from steady support through its own buyback initiative. On Jan. 6, the group kicked off a $1.2 billion share repurchase programme, aiming to wrap it up by Dec. 18, 2026, at the latest. A buyback means the company is buying back its own stock, usually cutting the number of shares outstanding.

The stock kicked off the day at 1,164.5 pence, moving within a narrow band since. Volume stood near 3.5 million shares, per data from the .

Prudential plc, the insurer listed in London, concentrates on markets in Asia and Africa. It is unrelated to the U.S. company Prudential Financial.

This week, the stock’s direction could depend more on interest rates and risk appetite than on company news, as global investors await clues from central banks on whether borrowing costs will remain elevated for an extended period.

But the situation works both ways. A shift to risk-off—whether sparked by new trade tensions, a spike in market volatility, or a sudden move in bond yields—could hit life insurers fast. Prudential’s international exposure only adds currency volatility to the mix.

Traders are waiting on the Fed’s next move to spark the market’s next big shift. Meanwhile, Prudential investors have their sights set on the company’s full-year 2025 results, due March 19.

Stock Market Today

  • Stock Market Today May 20: Nasdaq Rises 1.5% on Renewed Risk Appetite
    May 20, 2026, 5:43 PM EDT. The S&P 500 gained 1.08% to 7,432.97, Nasdaq rose 1.54% to 26,270.36, and Dow advanced 1.31% to 50,009.34 amid falling oil prices and easing Treasury yields. AI hardware stocks like AMD and Super Micro Computer led gains, with Nvidia up 1.3% before its earnings report. Software names Salesforce and CrowdStrike also recovered. Hasbro declined nearly 9% despite beating earnings forecasts due to cautious guidance. Investor optimism reflects hopes for an end to the U.S.-Iran conflict, lowering West Texas Intermediate crude by 5% to $99 a barrel. Nvidia's earnings beat was met with muted reaction as investors awaited stronger sales forecasts. The Motley Fool highlighted other top stock picks, noting Nvidia and Netflix's historic outperformance over the S&P 500.

Latest articles

MicroAlgo Shares Surge 40% as Quantum Release Drives MLGO Spike

MicroAlgo Shares Surge 40% as Quantum Release Drives MLGO Spike

20 May 2026
MicroAlgo shares surged 39.95% to $5.36 after the company announced a quantum image-processing algorithm, with volume reaching 9.74 million shares versus a 447,270 average. The stock hit $6.87 intraday before slipping to $5.22 after hours. No customer deals, revenue targets, or product launch dates were disclosed. Market cap stood near $66.7 million at the close.
Immunovant Stock Surges 35% After Arthritis Drug Data: Why Wall Street Is Repricing IMVT

Immunovant Stock Surges 35% After Arthritis Drug Data: Why Wall Street Is Repricing IMVT

20 May 2026
Immunovant shares jumped 35.3% to $35.56 after reporting 16-week data showing its drug IMVT-1402 produced ACR20, ACR50, and ACR70 response rates of 72.7%, 54.5%, and 35.8% in difficult-to-treat rheumatoid arthritis. Roivant Sciences, its majority owner, rose 14.9%. No new safety signals were reported. The trial enrolled 170 patients, most of whom had failed two prior advanced therapies.
FuelCell Energy surges as AI-fueled rally hits again, analysts wary

FuelCell Energy surges as AI-fueled rally hits again, analysts wary

20 May 2026
FuelCell Energy shares surged 16.5% to $20.22 Wednesday, rebounding after a two-day selloff. The move tracked a 1.5% gain in the Nasdaq Composite and renewed interest in companies supplying power to AI data centers. FuelCell reported a $26.1 million quarterly loss and a declining backlog, despite higher revenue and new data-center proposals. Peers traded mixed, with Bloom Energy up and Plug Power down.
Lloyds Banking Group share price lifts as profit-target talk grows ahead of results
Previous Story

Lloyds Banking Group share price lifts as profit-target talk grows ahead of results

UAMY stock jumps nearly 10% in premarket as antimony prices firm and China supply data hits tape
Next Story

UAMY stock jumps nearly 10% in premarket as antimony prices firm and China supply data hits tape

Go toTop